Navigation Links
Idenix Pharmaceuticals Reports First Quarter 2008 Financial Results
Date:4/29/2008

in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by hepatitis C virus and HIV. For further information about Idenix, please refer to http://www.idenix.com.

Forward-looking Statements

This press release contains "forward-looking statements" within the meaning of The Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified by the use of forward-looking terminology such as "expect," "plans," "anticipates," "will," or similar expressions, or by express or implied statements with respect to the company's clinical development programs or commercialization activities in HIV or hepatitis C, or any potential pipeline candidates and expectations with respect to additional milestone payments and cash balances at the end of 2008. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantees that historical sales of Tyzeka/Sebivo will in any way suggest future royalty payments or royalty rates owed to the company, or that the company will advance any clinical product candidate or other component of its potential pipeline to the clinic, to the regulatory process or to commercialization. In particular, management's expectations could be affected by unexpected regulatory actions or delays; uncertainties relating to, or unsuccessful results of, clinical trials, including additional data relating to the ongoing clinical trials evaluating its product candidates; the company's ability to obtain additional funding required to conduct its research, development and commercialization activities; the company's dependence on its collaboration with Novartis P
'/>"/>

SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Idenix Pharmaceuticals Presents Positive Preclinical Data on HCV Programs at The Annual Meeting of The European Association for the Study of the Liver (EASL)
2. Idenix Pharmaceuticals Provides Update on Hepatitis C Pipeline at JP Morgan Healthcare Conference
3. Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Bavituximab Phase II Breast Cancer Trial
4. Poniard Pharmaceuticals Announces Final Picoplatin Data from Phase 2 Small Cell Lung Cancer Trial Demonstrating Survival Benefit
5. Strativa Pharmaceuticals Announces Phase III Results for Loramyc(R) to Treat Oropharyngeal Candidiasis
6. Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
7. Shareholder Class Action Filed Against Vertex Pharmaceuticals Incorporated by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
8. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
9. Alseres Pharmaceuticals Expands Sites for the First Stage of the ALTROPANE(R) Phase III Clinical Trial Program
10. Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations
11. Sunesis Pharmaceuticals Reports Data from Nonclinical Studies of SNS-032 at the Annual Meeting of the American Association for Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... April 20, 2015   Gateway Rehab ... Training Institute today expanded its Naloxone: Increasing Access, ... A $50,000 grant from the Staunton Farm ... possible.  The yearlong research project, ... and their family members upon completion of treatment ...
(Date:4/20/2015)... Pharmaceutical Research and Manufacturers of America,s (PhRMA) member companies ... research and development (R&D) of new innovative treatments and ... R&D spending – both public and private – in ... R&D numbers, the result of a recent survey of ... PhRMA 2015 Biopharmaceutical Research Industry Profile ...
(Date:4/20/2015)... STAMFORD, Conn. , April 20, 2015 /PRNewswire/ ... announced that Alan Butcher has joined ... & Business Development. Alan will have responsibility for ... commercial, near-commercial, and development-stage products that would benefit ... bringing aboard a proven leader," said Purdue President ...
Breaking Medicine Technology:Gateway Rehab and the Kenneth S. Ramsey, PhD Research and Training Institute expand Naloxone: Increasing Access, Saving Lives research project to outpatient locations 2Gateway Rehab and the Kenneth S. Ramsey, PhD Research and Training Institute expand Naloxone: Increasing Access, Saving Lives research project to outpatient locations 3PhRMA Member Companies Invested $51.2 Billion in R&D in 2014 2PhRMA Member Companies Invested $51.2 Billion in R&D in 2014 3Purdue Pharma Names J. Alan Butcher Senior Vice President of Licensing & Business Development 2
... RUTHERFORD, N.J., Nov. 1, 2011 Cambrex Corporation (NYSE: ... financial results will be released on Thursday, November 3, ... Company will host a conference call to discuss the ... CallWhen: , Friday, November 4, 2011 at 8:30 a.m. ...
... Fla., Nov. 1, 2011 When you are behind the ... move – looking at vehicles ahead and to the side, ... shifting your gaze inside and outside your vehicle in order ... or change a radio station. During darkness these ...
Cached Medicine Technology:Steering Drivers in the Right Direction, "Healthy Vision™ With Dr. Val Jones" Radio Show Offers Information, Advice About Driving in the Dark 2Steering Drivers in the Right Direction, "Healthy Vision™ With Dr. Val Jones" Radio Show Offers Information, Advice About Driving in the Dark 3
(Date:4/20/2015)... (PRWEB) April 20, 2015 Saint Joseph Regional ... 15 Top Health Systems by Truven Health Analytics, a leading ... quality of healthcare. SJRMC has been recognized by Truven Health ... the past four years. , According to Truven Health Analytics' ... Health Systems, in matchups with their peers, set the standard ...
(Date:4/20/2015)... A recent cross-sectional survey involving fibromyalgia patients ... 10 most beneficial therapies for fibromyalgia, no drugs were mentioned, ... only approved drugs were named. , “The biggest problem ... is only felt as long as the patient is taking ... “On the other hand, aerobic exercise and other non-drug approaches ...
(Date:4/20/2015)... 2015 Western Connecticut Health Network ... NEA-BC, FAAN who was named The Beatrice Hofstadter ... in September 2014, is transitioning from her current ... the development of Western Connecticut Health Network’s Nurse ... Donahue will be responsible for the identification and ...
(Date:4/20/2015)... 2015 Advance Home Care Supply ... that many customers would prefer not to share with others. ... a discreet delivery method allowing customers to order the products ... home without fear of a neighbor or passerby knowing what ... available now on all orders and no minimum order limit ...
(Date:4/20/2015)... Genuine fat loss results can seem virtually impossible ... the past. But what failed dieters and gym-goers don’t realize ... by adhering to five simple principles. , 1. Nutrition, No ... hours one spends working at the gym, a poor diet ... nutritional mean plan does not mean starvation, calorie counting or ...
Breaking Medicine News(10 mins):Health News:SJRMC Named a 15 Top Health System by Truven Health Analytics 2Health News:SJRMC Named a 15 Top Health System by Truven Health Analytics 3Health News:Medical Doctor in Huntsville Reveals That Aerobic Exercise Offers Best Results in Fibromyalgia Treatment 2Health News:Nursing Executive to Develop and Lead Nursing Leadership Program at Western Connecticut Health Network 2Health News:Advance Home Care Supply Proud to Offer Discreet Delivery For All Orders 2Health News:Advance Home Care Supply Proud to Offer Discreet Delivery For All Orders 3Health News:Guarantee Fat Loss Results With 5 Easy Tips 2Health News:Guarantee Fat Loss Results With 5 Easy Tips 3
... light to medium smokers, daily intake of non-steroidal anti-inflammatory drugs ... ,Norwegian scientists, who had conducted the studies, had said ... 65% less chance of having oral cancer than others, when ... suggested that NSAID might have anti carcinogenic effect on smokers ...
... improve the rate of recovery for the patients. Patients who had ... // having a favorable recovery than persons who have not been ... had the chance of 2.6 times more of a favorable recovery ... who had ischemic stroke to assess the usefulness of statins before ...
... a report prepared for the Health And Safety Executive, a ... of the employees,// researchers had found out that working in ... people work during nights, the levels of melatonin, or the ... with the new sleep routines. As a result, people do ...
... Technologies had developed a robotic dental drill that can make ... dental surgeon. The drill is all set to bring relief ... less painful than the common manual procedure. ,A dental ... and is generally imbedded in the gum through a long ...
... cancer is enhanced by eating processed meats, said the researchers ... Honolulu. ,Previous studies have tried to relate meat with ... have been proved to enhance carcinogenic growth in the pancreas. ... but the chemical agents that process the meat for long ...
... US department of Agriculture has recently unveiled a new guide to ... different needs. ,Based on the idea that same diet pattern ... on age, sex and the level of activity. The new plan ... gives you a diet chart once you feed in the required ...
Cached Medicine News:
... Right for the typical patient, right ... Medical ICDs, you have the ability to ... when you least expect themeven after implant. ... you need to be prepared in almost ...
... ID and Visitor Control System. A bar code-based ... compare and verify identity of those people authorized ... document interactions with all visitors and staff who ... child patient. It also helps to reduce the ...
... global companies a cost-effective and dependable ... initiatives. With die-cast metal construction, centralized ... options, and complex multi-language font support, ... Plus, the fully integrated RFID reader/encoder ...
... solid, tested XiIIIPlus platform, the R110Xifor ... of on-demand printing flexibility in tag ... such as XML for seamless integration ... inlay positioning, multiple power levels, statistics ...
Medicine Products: